Thanks mjshackI, , then the question needs to be asked " Why is their an excess cost of $4m to $5m compared to the previous quarter?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025